Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Brock W.
In der Rubrik Zeitschriften haben wir 1 Beitrag für Sie gefunden
-
Stephan A. Steines, PhD
MerkenNeed for Dedicated Equipment?
Rubrik: GMP / GLP / GCP
(Treffer aus pharmind, Nr. 05, Seite 718 (2014))
Hildebrandt K | Steines S | Brock W
Need for Dedicated Equipment? / Manufacturing of Antineoplastics and Other Hazardous Substances · Hildebrandt K, Steines S, Brock W · 1Dottikon Exclusive Synthesis AG, Dottikon, Switzerland und 2Brock Scientific Consulting, Montgomery Village, MD, USA
A major concern related to the production of active pharmaceutical agents (APIs) and pharmaceutical intermediates is the cross-contamination of subsequently manufactured products with substances that are highly toxic or that have high biological activity. This issue is addressed in Good Manufacturing Practice (GMP) guidelines. EudraLex [ 1 ], a compendium of Good Manufacturing Practices (GMPs), clearly states that contamination of a starting material or of a product by another material or product must be avoided. The risk of accidental cross-contamination arises from the uncontrolled release of dust, gases, vapors, etc. from materials and products in process as well as from ...
